Today: 13 May 2026
Browse Category

NASDAQ:AVTX 6 May 2026

Avalo Therapeutics Stock Jumps As $375 Million Raise Follows Phase 2 HS Trial Win

Avalo Therapeutics Stock Jumps As $375 Million Raise Follows Phase 2 HS Trial Win

Avalo Therapeutics priced a $375 million public offering after reporting positive Phase 2 results for abdakibart in hidradenitis suppurativa. The company will sell 19.73 million shares at $17.75 each and pre-funded warrants for 1.4 million shares. Shares rose 34% to $21.73 by midday. The Phase 2 trial showed HiSCR75 response rates of over 42% for both dosing regimens versus 25.6% for placebo.
6 May 2026
··

Stock Market Today

  • Pelagos Insurance Q1 CY2026 Earnings Beat Expectations Despite Revenue Decline
    May 13, 2026, 5:29 PM EDT. Pelagos Insurance (NYSE:PLGO) reported Q1 CY2026 earnings surpassing analysts' estimates with a GAAP EPS of $1.15, 19.1% above the consensus of $0.97. Revenue was $610.6 million, down 7.3% year on year but still 4.7% ahead of forecasts. Net premiums earned fell 5.7% to $568.5 million yet beat estimates by 8.1%. The combined ratio, a measure of underwriting profitability, improved to 86.6%, beating analyst expectations by 90 basis points. Book value per share rose 21% year over year to $26.22. CEO Dan Burrows highlighted strong premium growth and a healthy 15.2% operating return on average equity. Pelagos continues to leverage its specialty insurance model and underwriting partnerships to drive profitable growth amid evolving market conditions.

Latest articles

Fermi Stock Faces A High-Stakes Q1 Test As Founder Fight Deepens

Fermi Stock Faces A High-Stakes Q1 Test As Founder Fight Deepens

13 May 2026
Toby Neugebauer and allied shareholders filed new proxy materials to press for board changes at Fermi Inc., despite the board’s claim that the May 29 special meeting has been canceled. The group plans to use separate proxy cards for the disputed May 29 vote and a shareholder-called meeting expected around June 30. Fermi’s board opposes Neugebauer’s push for control and a quick sale. First-quarter results are due Thursday.
Fervo Energy Stock Jumps 35% in Nasdaq Debut as AI Power Demand Pulls Geothermal Into Wall Street’s Spotlight

Fervo Energy Stock Jumps 35% in Nasdaq Debut as AI Power Demand Pulls Geothermal Into Wall Street’s Spotlight

13 May 2026
Fervo Energy shares closed at $36.54, 35% above the $27 IPO price, in their Nasdaq debut Wednesday, valuing the company at $10.36 billion. The Houston geothermal developer raised $1.89 billion by selling 70 million shares. Fervo reported 2025 revenue of $138,000 and a net loss of $57.8 million. The company holds $7.2 billion in potential contracted revenue but has yet to deliver commercial power.
Wix Stock Plunges 27% After Q1 Earnings Miss as AI Spending Spooks Investors

Wix Stock Plunges 27% After Q1 Earnings Miss as AI Spending Spooks Investors

13 May 2026
Wix shares fell 27.1% to $55.32 after first-quarter adjusted earnings missed estimates and the company posted a GAAP net loss of $57.5 million. Revenue rose 14% to $541.2 million, but non-GAAP operating margin dropped to 5% from 21% a year earlier. JPMorgan cut its price target to $86, citing ongoing heavy investment. Research and development costs jumped to $178.2 million from $127.5 million.
Cisco Stock Surges After Q3 Earnings as AI Orders Spark Job Cuts and Bigger Forecast

Cisco Stock Surges After Q3 Earnings as AI Orders Spark Job Cuts and Bigger Forecast

13 May 2026
Cisco shares rose 14% in after-hours trading Wednesday after the company raised its annual revenue forecast and announced nearly 4,000 job cuts to fund AI investments. Fiscal Q3 revenue reached $15.8 billion, up 12%, with net income of $3.4 billion. Cisco now expects fiscal 2026 revenue of up to $63 billion. The company reported $5.3 billion in AI infrastructure orders so far this year.
Go toTop